Alphabet

By Laura Lovett 03:17 pm August 25, 2020
Alphabet’s life science subsidiary Verily is jumping into the health insurance game with the launch of its new venture Coefficient Insurance Company.  The tech-enabled payer will be backed by Swiss Re Corporate Solutions, which specializes in data-driven risk assessments.  Coefficient, which is categorized as a Verily subsidiary, is targeted at self-funded employers and is pitched as stop-loss...
By MobiHealthNews 02:38 pm August 7, 2020
Shortly before news broke that Teladoc was set to acquire Livongo, the chronic disease management company announced its quarterly earnings results. On Aug. 5 it announced that its second quarter total revenue came in at $91.9 million, which was up 125% YoY. The company reported a GAAP gross margin of 76.6% and non-GAAP gross margin of 77.3%. The company attributed the gains to its growing...
By Dave Muoio 11:52 am August 4, 2020
It's been about nine months since Google officially announced plans to acquire Fitbit. The deal was expected to close in Q2 2020, but antitrust concerns from U.S. and E.U. regulators have so far stalled the purchase. That delay will likely run a fair bit longer with the European Commission announcement that its preliminary probe of the purchase will now expand into a full-scale investigation...
By Laura Lovett 02:13 pm July 16, 2020
Cityblock, a startup focused on used tech to tackling health disparities, has raised $53.5 million in what it describes as Series B+ funding. Kinnevik AB led the round with participation from AIMS Imprint of Goldman Sachs Asset Management and Alphabet, as well as existing investors.  This comes roughly a year after a $63 million Series B funding in April of 2019, and close to two years after the...
By Laura Lovett 04:20 pm June 26, 2020
Health insurtech company Oscar Health scored a whopping $225 million in Series C funding from Google’s parent company Alphabet, General Catalyst, Khosla Ventures, Lakestar, Thrive Capital and Baillie Gifford.  This comes roughly two years after the company announced a $165 million funding round led by Brian Singerman and Founders Fund.  WHAT THEY DO  The company offers direct-to-consumer health...
By MobiHealthNews 04:23 pm April 27, 2020
Thanks, but we've got this. The U.K. has decided not to use Apple and Google’s much-anticipated Bluetooth contact tracing tool as originally planned, according to the BBC. Apple and Google’s model pitches a decentralized system for tracing, while the NHSX – which works on the UK’s digital health efforts – is proposing a centralized system. NHS officials told the BBC that the centralized system...
By Dave Muoio 03:23 pm March 16, 2020
Alphabet's Verily has launched a website where California residents can complete a short survey regarding their current condition and, if they meet certain criteria, could be referred to a nearby mobile COVID-19 testing site. Conducted through Verily's Project Baseline population health effort and developed in collaboration with federal, state and local public health authorities, the triage...
By Dave Muoio 03:05 pm January 8, 2020
Dr. Vindell Washington, the head on the Office of the National Coordinator for Health IT from August 2016 to January 2017, is the latest to jump on board at Alphabet's Verily, according to tweets from fellow ONC vet-turned-Googler Dr. Karen DeSalvo, as well as from Verily’s communications lead. He comes directly from a position as Blue Cross and Blue Shield of Louisiana’s chief medical officer....

Photo by Carsten Koall/Getty Images

By MobiHealthNews 11:25 am December 13, 2019
It’s been a big year for Google’s parent company Alphabet. Once upon a time, Google’s role in the health world was chiefly associated with "Googling" symptoms, but much has changed for the Silicon Valley giant. This year Google made major moves in the health industry—making waves when it announced a plan to acquire Fitbit and even dipping into the EHR space by demoing a new search feature. ...
By Dave Muoio 03:48 pm December 10, 2019
Sanofi announced a major strategy shift today that will end the pharma’s diabetes and cardiovascular R&D efforts in favor of a reinvigorated focus on growing its immunology and vaccine businesses. Among the fallout of this new game plan is Onduo, the pharma’s diabetes management joint venture with Verily that the two companies invested $500 million into back in 2016, according to the company’...